Related Experiment Videos
Mitogen-activated protein (MAP) kinase during the acquisition of meiotic competence by growing oocytes of the mouse
1Department of Pathology, McGill University, Montreal, Canada.
Abstract:
During the growth phase of oogenesis, oocytes acquire the ability to undergo meiotic maturation. Although the molecular basis of this meiotic competence is unknown, specific differences in microtubular organization exist between incompetent and competent mammalian oocytes. Mitogen-activated protein (MAP) kinase has been implicated in microtubular regulation and is present in fully grown competent oocytes of mice, suggesting a possible role for this protein in the acquisition of meiotic competence. We report that the MAP kinase species, p42ERK2 and p44ERK1, were detectable by immunoblotting in incompetent oocytes at the early stages of oocyte growth and throughout subsequent growth and acquisition of competence. In partially competent oocytes, which can enter metaphase but cannot complete the first meiotic division, both p42ERK2 and p44ERK1 became phosphorylated, as judged by retarded electrophoretic mobility, and a morphologically normal spindle was assembled. In incompetent oocytes, which cannot enter metaphase, p42ERK2 and p44ERK1 remained nonphosphorylated. When these oocytes were treated with okadaic acid, an inhibitor of protein phosphatases 1 and 2A, a portion of them entered metaphase and the slow-migrating phosphorylated forms of p42ERK2 and p44ERK1 were observed. These phosphorylated forms appeared more rapidly, relative to the time of entry into metaphase, than during maturation of fully competent oocytes. The remaining incompetent oocytes, which did not enter metaphase during okadaic acid treatment, also did not generate slow-migrating p42ERK2 and p44ERK1. These results suggest that the acquisition of meiotic competence during oocyte growth is not linked to the de novo appearance of p42ERK2 or p44ERK1, that the failure of partially competent oocytes to complete meiosis I reflects a defect acting downstream or independently of MAP kinase phosphorylation, and that the ability of meiotically incompetent oocytes to generate phosphorylated forms of p42ERK2 and p44ERK1 in response to okadaic acid is linked to the ability to enter metaphase.
Insights
Mitogen-activated protein (MAP) kinase phosphorylation is present in oocytes throughout growth. Its phosphorylation is linked to metaphase entry, but not the completion of meiosis I in oocytes.
Area of Science:
- Cell Biology
- Developmental Biology
- Reproductive Biology
Background:
- Oocyte maturation is crucial for fertility.
- Meiotic competence acquisition is not fully understood.
- Microtubule organization differs between competent and incompetent oocytes.
Purpose of the Study:
- Investigate the role of MAP kinase in oocyte meiotic competence.
- Determine if MAP kinase activation is necessary for meiotic progression.
- Clarify the molecular basis of meiotic competence acquisition.
Main Methods:
- Immunoblotting to detect MAP kinase species (p42ERK2, p44ERK1).
- Electrophoretic mobility to assess MAP kinase phosphorylation.
- Okadaic acid treatment to inhibit phosphatases and induce maturation.
Main Results:
- MAP kinase species were present throughout oocyte growth.
- Phosphorylated MAP kinase correlated with metaphase entry in partially competent oocytes.
- Incompetent oocytes showed non-phosphorylated MAP kinase, but could enter metaphase upon okadaic acid treatment.
Conclusions:
- MAP kinase presence, not de novo appearance, is linked to meiotic competence.
- Defects in completing meiosis I occur downstream of MAP kinase phosphorylation.
- MAP kinase phosphorylation ability in incompetent oocytes correlates with metaphase entry potential.